Companies: 10,795·Total market cap: $144.5T
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANIPNASDAQHealthcare● Active
$80.13
$-0.98(-1.21%)
Market Cap$1.8B
P/E Ratio
52W High$99.5
52W Low$59.61
Overview

ANI Pharmaceuticals, Inc. (ANIP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ANIP · as of Jun 8, 2026

Key Statistics

EPS (TTM)$4.11anip eps ttm · anip earnings per shareEarnings history
PE Ratio (TTM)19.5×anip pe ratio ttm · anip price to earningsPE Ratio deep dive
Revenue (TTM)$923.7Manip revenue ttm · anip annual revenueFull revenue history
Dividend YieldNo Dividenddoes anip pay dividends · anip dividend yieldDividend history
Shares Outstanding20.1Manip shares outstanding · anip floatShares outstanding history
Next EarningsAug 14, 2026Est.anip earnings date · anip next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$883.4M▲ +43.78% YoY
202320242025
ani pharmaceuticals, inc. revenue · anip revenue 2025
FY 2025Net Income$78.3M▲ +522.94% YoY
202320242025
ani pharmaceuticals, inc. net income · anip profit 2025
FY 2025EPS$3.50▲ +436.54% YoY
202320242025
anip eps · ani pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $923.7MNet Income: $89.7MEPS: $4.11View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis anip a buy · anip analyst rating
Strong Buy
0
Buy
7
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$124.00Low
$80.13Current
$124.00Avg Target54.75% upside
$124.00High
anip price target · anip 12 month forecast

Total: 10 · Buy rate: 70.0%

The ANIP analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $124.00, representing +54.75% upside from the current price of $80.13.

Stock Performance

Full History
1D+2.41%
1W+9.25%
1M-0.92%
3M+9.55%
YTD+2.75%
1Y+28.38%
5Y+131.15%

About ANI Pharmaceuticals, Inc.

CEONikhil Lalwani
IPO DateMay 5, 2000
Employees897
CountryUS

ANI Pharmaceuticals, Inc. operates as a biopharmaceutical firm, concentrating on the development, production, and commercialization of both proprietary (branded) and unbranded (generic) prescription m…

what is ani pharmaceuticals, inc. · anip stock overview · ani pharmaceuticals, inc. company profile · who is ani pharmaceuticals, inc. ceo · anip NASDAQ · ani pharmaceuticals, inc. headquarters · ani pharmaceuticals, inc. business segments

About Stock Overview & Key Data

ANI Pharmaceuticals, Inc. (ANIP) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 5, 2000. As of the latest trading session, ANIP stock price is $80.13, with a market capitalization of $1.8B. The stock has returned +28.38% over the past 12 months and +2.75% year-to-date.

According to 10 Wall Street analysts, the consensus rating for ANI Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $124.00. In fiscal year 2025, ANI Pharmaceuticals, Inc. reported revenue of $883.4M and net income of $78.3M. For detailed data — including ANI Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, ANI Pharmaceuticals, Inc. (ANIP) stock price is $80.13. The stock is traded on NASDAQ under the ticker symbol ANIP. The 52-week range is $59.61 – $99.50.

ANIP stock priceANIP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice